Indefinite Delivery Contract SPE2DU25D4118

The federal contract IDV award was issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The IDV contract, valued at $999,999,999, has an ultimate completion date of December 31, 2036 and provides a vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The original solicitation plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, U.S. Coast Guard, and U.S. Naval Fleet. The contracts will have a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. The procurement is fully competitive, with the intent to make multiple primary supplier awards and one backup supplier award. The contracts will cover pharmaceutical products in the 6505 stock catalog/schedule and the current National Drug Code database, including brand-name, generic, and specialty medications, as well as related medical supplies and devices.